Non-mutational phenotypic evolution in metastatic melanoma: the role of the epidermal growth factor receptor and epithelial-mesenchymal transition-like processes in treatment resistance.
Non-mutational phenotypic evolution in metastatic melanoma: the role of the epidermal growth factor receptor and epithelial-mesenchymal transition-like processes in treatment resistance.
批准号:
nhmrc : 1055456
负责人:
Dr Miles Andrews
金额:
$9.4万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Postgraduate Scholarships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31
中文摘要
表型改变已被确定在多种设置有关黑色素瘤的进展和转移。我们已经确定了表型可塑性、上皮细胞向间质转化和治疗耐药性的出现之间存在一定程度的重叠。本项目将进一步研究这些变化的机制,重点研究表皮生长因子的作用。
英文摘要
Phenotypic change has been identified in multiple settings relating to melanoma progression and metastasis. We have identified a degree of overlap between features of phenotypic plasticity, epithelial-to-mesenchymal transition, and the emergence of treatment resistance. This project will further examine mechanisms underlying these changes, focusing on the role of the epidermal growth factor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deriving actionable strategies to enhance cancer immunotherapy response
-
批准号:nhmrc : 1148680
-
项目类别:Early Career Fellowships
-
资助金额:$29.82万
-
财政年份:2018
-
负责人:Dr Miles Andrews
-
依托单位:
Deriving actionable strategies to enhance cancer immunotherapy response
-
批准号:nhmrc : GNT1148680
-
项目类别:Early Career Fellowships
-
资助金额:$43.88万
-
财政年份:2018
-
负责人:Dr Miles Andrews
-
依托单位:
Characterisation of the role of mesenchymal phenotypes and EGFR in treatment-resistant melanoma.
-
批准号:nhmrc : GNT1055456
-
项目类别:Postgraduate Scholarships
-
资助金额:$11.32万
-
财政年份:2013
-
负责人:Dr Miles Andrews
-
依托单位:
海外基金